Dallas pharmacist pleads guilty for role in ‘pill mill’ operation

The registered pharmacist who owned and operated GenPharm Pharmacy in Desoto, Texas, pled guilty for her role in a cooperative effort to illicitly distribute opioids for-profit.

Advertisement

Ndufola Kigham is the fourth defendant to plead guilty in the Dallas-area “pill mill” scandal. The other defendants consist of a medical clinic owner, another pharmacist and an osteopathic physician. The guilty plea implicates Ms. Kigham in the acts of filling prescriptions for 30mg oxycodone written for multiple individuals and dispensing the drugs to a single individual whose name did not match the name on the prescription.

“As part of the conspiracy, individuals, often homeless or of limited means, were recruited and paid to pose as patients at medical clinics … to obtain prescriptions [and] to fill those prescriptions at designated pharmacies,” the Drug Enforcement Administration said in a release.

Under her guilty plea, Ms. Kigham agreed to pay a $9,500 fine prior to sentencing and faces a maximum statutory sentence of three years in federal prison. Sentencing is slated for May 26, 2017.

More articles on legal issues: 
TeamHealth to pay $60M to resolve false claims case 
Tenet indictment signals new era of healthcare fraud investigations 
Nurse files $6.5M retaliation suit against HCA, Florida hospital

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Download Whitepaper

The cost-saving opportunity most health systems overlook

Many hospitals and health systems scrutinize staffing, service lines, and payer contracts for savings. Fewer look at one of their largest assets: real estate.…

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.